These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2022031)

  • 1. Endothelin has biological actions at pathophysiological concentrations.
    Lerman A; Hildebrand FL; Aarhus LL; Burnett JC
    Circulation; 1991 May; 83(5):1808-14. PubMed ID: 2022031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic endothelin-induced pressor and renal actions in conscious dogs do not require altered ANG II formation.
    Wilkins FC; Kassab S; Kato T; Mizelle HL; Opgenorth TJ; Granger JP
    Am J Physiol; 1995 Feb; 268(2 Pt 2):R395-402. PubMed ID: 7864234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic hemodynamics and renal function during long-term pathophysiological increases in circulating endothelin.
    Wilkins FC; Alberola A; Mizelle HL; Opgenorth TJ; Granger JP
    Am J Physiol; 1995 Feb; 268(2 Pt 2):R375-81. PubMed ID: 7864231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal and hemodynamic effects of endothelin in anesthetized dogs.
    Tsuchiya K; Naruse M; Sanaka T; Naruse K; Zeng ZP; Nitta K; Demura H; Shizume K; Sugino N
    Am J Hypertens; 1990 Oct; 3(10):792-5. PubMed ID: 2222945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
    Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
    Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated cardiac, renal, and endocrine actions of endothelin.
    Miller WL; Redfield MM; Burnett JC
    J Clin Invest; 1989 Jan; 83(1):317-20. PubMed ID: 2642921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs.
    Donckier JE; Hanet C; Berbinschi A; Galanti L; Robert A; Van Mechelen H; Pouleur H; Ketelslegers JM
    Circulation; 1991 Dec; 84(6):2476-84. PubMed ID: 1835679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications.
    Chan DP; Clavell A; Keiser J; Burnett JC
    J Hypertens Suppl; 1994 Jul; 12(4):S43-9. PubMed ID: 7965274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction.
    Lerman A; Sandok EK; Hildebrand FL; Burnett JC
    Circulation; 1992 May; 85(5):1894-8. PubMed ID: 1572045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-mediated cardiorenal hemodynamic and neuroendocrine effects are attenuated by nitroglycerin in vivo.
    Miller WL; Cavero PG; Aarhus LL; Heublein DM; Burnett JC
    Am J Hypertens; 1993 Feb; 6(2):156-63. PubMed ID: 8385958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
    Cannan CR; Burnett JC; Brandt RR; Lerman A
    Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased endothelin in experimental heart failure.
    Margulies KB; Hildebrand FL; Lerman A; Perrella MA; Burnett JC
    Circulation; 1990 Dec; 82(6):2226-30. PubMed ID: 2242543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs.
    Teerlink JR; Carteaux JP; Sprecher U; Löffler BM; Clozel M; Clozel JP
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H432-40. PubMed ID: 7840293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin receptor subtypes in the in vivo regulation of renal function.
    Clavell AL; Stingo AJ; Margulies KB; Brandt RR; Burnett JC
    Am J Physiol; 1995 Mar; 268(3 Pt 2):F455-60. PubMed ID: 7900845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal actions of endothelin: interaction with prostacyclin.
    Chou SY; Dahhan A; Porush JG
    Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological role for the endothelin-A receptor in aortic cross-clamping.
    Stingo AJ; Clavell AL; Aarhus LL; Burnett JC
    Hypertension; 1993 Jul; 22(1):62-6. PubMed ID: 8319993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of ANP with endothelin on cardiovascular, renal, and endocrine function.
    Ota K; Kimura T; Shoji M; Inoue M; Sato K; Ohta M; Yamamoto T; Tsunoda K; Abe K; Yoshinaga K
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E135-41. PubMed ID: 1531732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin in thoracic inferior vena caval constriction model of heart failure.
    Underwood RD; Aarhus LL; Heublein DM; Burnett JC
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H951-5. PubMed ID: 1415622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonism.
    Rasmussen TE; Jougasaki M; Supaporn T; Hallett JW; Brooks DP; Burnett JC
    Am J Physiol; 1998 Jan; 274(1):R131-8. PubMed ID: 9458909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous infusion of endothelin-1 in pregnant sheep.
    Greenberg SG; Baker RS; Yang D; Clark KE
    Hypertension; 1997 Dec; 30(6):1585-90. PubMed ID: 9403587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.